There is one clinical trial.
The purpose of this study is to determine if medically tailored meals provided for either 2 weeks or 4 weeks (1 meal per day) to a Kaiser Permanente Colorado (KPCO) member after hospital discharge will improve their health. Medically tailored meals (MTM) are meals that are approved by a dietitian and shown to help people with certain health conditions.
Description: Measured through the Hospital Anxiety and Depression Scale. 0 = Minimum. 21 = Maximum. Higher score is worse outcome.Measure: Anxiety and Depression measured through the Hospital Anxiety and Depression Scale Time: A change in score from baseline to 60 days
Description: Measured through the Katz Activities of Daily Living. Minimum = 0, Maximum = 6. Higher score is better outcome.Measure: Functional Status measured through the Katz Activities of Daily Living Scale Time: A change in score from baseline to 60 days
Description: Measured through time of discharge through re-hospitalization or Emergency Department visitMeasure: Re-hospitalization and Emergency Department Visits Time: 60 days from hospital discharge
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports